Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapyXiaoli Pan, Liang Ouyang, Lu Feng et al.|Acta Pharmaceutica Sinica B|2022Cited by 83
Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trialHuijie Bian, Ye Zhang, Zhaohui Zheng et al.|Signal Transduction and Targeted Therapy|2021Cited by 66